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ABSTRACT  
Obesity is associated with metabolic dysfunction, 
including insulin resistance and hyperinsulinemia, 
and with disorders such as cardiovascular disease, 
osteoporosis, and neurodegeneration. Typically, 
these pathologies are examined in discrete model 
systems and with limited temporal resolution, and 
whether these disorders co-occur is therefore 
unclear. To address this question, here we 
examined multiple physiological systems in male 
C57BL/6J mice following prolonged exposure to a 
high-fat/high-sucrose diet (HFHSD). HFHSD-fed 
mice rapidly exhibited metabolic alterations, 
including obesity, hyperleptinemia, physical 
inactivity, glucose intolerance, peripheral insulin 
resistance, fasting hyperglycemia, ectopic lipid 
deposition, and bone deterioration. Prolonged 
exposure to HFHSD resulted in morbid obesity, 
ectopic triglyceride deposition in liver and muscle, 
extensive bone loss, sarcopenia, hyperinsulinemia, 
and impaired short-term memory. Although many 
of these defects are typically associated with aging, 
HFHSD did not alter telomere length in white blood 
cells, indicating that this diet did not generally 
promote all aspects of aging. Strikingly, glucose 
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homeostasis was highly dynamic. Glucose 
intolerance was evident in HFHSD-fed mice after 1 
week and was maintained for 24 weeks. Beyond 24 
weeks, however, glucose tolerance improved in 
HFHSD-fed mice, and by 60 weeks, it was 
indistinguishable from that of chow-fed mice. This 
improvement coincided with adaptive β-cell 
hyperplasia and hyperinsulinemia, without changes 
in insulin sensitivity in muscle or adipose tissue. 
Assessment of insulin secretion in isolated islets 
revealed that leptin, which inhibited insulin 
secretion in the chow-fed mice, potentiated 
glucose-stimulated insulin secretion in the HFHSD-
fed mice after 60 weeks. Overall, the excessive 
calorie intake was accompanied by deteriorating 
function of numerous physiological systems.  
INTRODUCTION 
Excessive consumption of calories is 
associated with deterioration of a range of 
physiological systems. While the impact of specific 
macronutrients per se on health is highly debated it 
is clear that diets enriched in sugar and fat result in 
obesity. It is widely recognised that obesity is a 
major risk factor for numerous diseases including 
type 2 diabetes, cardiovascular disease and at least 
9 types of cancer [1]. Hence, the epidemic of 
obesity spreading throughout the world represents 
one of the major challenges for future human 
health.  
Extensive studies in rodent models have 
shown that exposure to diets that resemble those 
commonly consumed by humans in modernised 
societies leads to a marked deterioration in a range 
of metabolic systems [2]. Presumably due to 
enhanced palatability and/or different 
macronutrient compositions (i.e. protein, 
carbohydrate and fat ratios) [3], diets high in sugar 
and/or a range of fats including both saturated and 
polyunsaturated fats invariably leads to excess 
calorie intake and drives animals toward a positive 
energy balance concomitant with obesity. This 
transition is associated with a rapid decline in whole 
body insulin sensitivity [4] ultimately resulting in 
compensatory hyperinsulinemia [4] and a state that 
resembles pre-diabetes in humans. Numerous labs 
have recapitulated these findings and such diet-
induced obesity models are widely used to study 
numerous facets of metabolic homeostasis and 
disease. For example, HFHSD feeding in mice is 
accompanied by alterations in circadian rhythm [5], 
gut microbiome [6] and inflammation [7] and these 
changes have been linked to metabolic dysfunction.   
Aside from its obvious role in metabolic 
disease, obesity is also linked to a range of other 
diseases. There is evidence implicating obesity and 
Western diets high in saturated fats and refined 
sugars in the development of musculo-skeletal [8, 
9], pulmonary [10], kidney [11] and neurological 
[12, 13] disorders. However, most studies involve 
analysis of one physiological system in isolation 
often with limited time resolution. Hence, there is a 
need for a temporal systematic analysis of multiple 
physiological parameters in one or more of these 
diet-induced obesity models to fully realise the 
overall impact of obesity on health as well as the 
temporal relationship between impairments in 
distinct tissues.  
In this study, we performed a 
comprehensive longitudinal analysis of the impact 
of a HFHSD on a range of physiological systems in 
male C57BL/6J mice. We observed a time resolved 
deterioration in the function of a multitude of 
physiological systems as mice became obese 
including torpor, sarcopenia, bone loss, 
neurological dysfunction as well as a range of 
metabolic disorders including hyperinsulinemia, 
insulin resistance, glucose intolerance and hepatic 
steatosis. Many of these effects emerged in a time-
dependent manner, either occurring rapidly, such as 
bone loss, or more slowly, such as impaired short-
term memory. The most complex set of adaptations 
was observed in glucose tolerance. HFHSD fed 
mice displayed rapid glucose intolerance and 
insulin resistance. These changes persisted almost 
unchanged for 24 weeks after which glucose 
intolerance, but not insulin resistance, gradually 
improved and ultimately resolved. This 
improvement was concomitant with increased β-
cell mass and augmented circulating insulin 
concentrations. Leptin, which has previously been 
shown to suppress glucose-stimulated insulin 
secretion in islets, had the opposite effect in islets 
isolated from mice fed a HFHSD for 60 weeks, 
suggesting that islet responses to leptin are 
dependent on dietary context and under these 
conditions leptin may promote insulin secretion in 
vivo. Our analysis provides a comprehensive 
assessment of the temporal adaptations to excess 
calorie intake in a host of physiological systems and 
highlights the pervasive effects of diet in multiple 
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tissues and lays the groundwork for further studies 
into the interaction between diet and health.  
RESULTS 
To dissect the temporal dynamics of 
metabolic, skeletal and neurological responses to 
diet we assessed indices of health in these systems 
in mice fed a control chow diet or a high fat high 
sucrose diet (HFHSD) for 60 weeks as a model of 
diet-induced obesity. At 60 weeks, HFHSD-fed 
mice consumed ~34% more energy per day (3.1 
kcal/g for chow; 4.7 kcal/g for HFHSD) (Fig. 1A 
and 1B) indicating that increased calorie intake in 
mice fed HFHSD was maintained throughout the 
feeding period. As expected, chow-fed mice 
consistently displayed a higher respiratory 
exchange ratio (RER), indicating predominant use 
of carbohydrates in both the light and dark cycles at 
all-time points studied (Fig. 1C). RERs were lower 
in HFHSD-fed mice, and lowered further with 
increasing time on the diet. This implies both an 
initial switch to fat as the major energy source, and 
continued adaptation to further increase fat use 
(Fig. 1C). We also observed a significant reduction 
in the activity of mice fed HFHSD after only 6 
weeks and this was maintained for the duration of 
the HFHSD feeding (Fig. 1D). Hence, HFHSD-fed 
mice consumed additional calories and were less 
physically active, placing these animals in a state of 
positive energy balance.  
Not surprisingly, the positive energy 
balance observed in HFHSD-fed mice resulted in 
gradual and profound increases in body mass (Fig. 
1E) and obesity. Adiposity was not changed in 
chow-fed mice over the course of 60 weeks, but 
rapidly increased in HFHSD-fed mice, plateauing 
after 40 weeks (Fig. 1F). We also measured distinct 
temporal patterns of ectopic triglyceride deposition 
in liver, quadriceps muscle and heart (Fig. 1G). 
Triglycerides were elevated in quadriceps after 6 
weeks HFHSD feeding and this was sustained for 
60 weeks. In contrast, increased levels of 
triglycerides was only observed in liver at 24 weeks 
and in heart at 60 weeks (Fig. 1G). The major 
increase in triglyceride in muscle and liver was 
measured at 24 weeks HFHSD, and was 
concomitant with the plateau in adiposity (Fig. 1F), 
suggesting a link between adipose storage capacity 
or maximum adiposity and ectopic lipid deposition. 
Lean mass was not different between diet groups 
across the time course (Fig. 1H) although after 24 
weeks exposure to the diets, HFHSD-fed mice, but 
not chow-fed mice, displayed a 15% decline in 
mass of some specific muscles indicative of 
accelerated sarcopenia at these sites (Fig. 1I). 
Overall, mice fed a HFHSD displayed increased 
caloric intake, lower physical activity and increased 
adiposity and body mass, providing a good model 
for the pathogenesis of diet-induced obesity in 
humans. 
High fat high sucrose diet feeding rapidly 
lowers bone density and strength - We next 
examined the temporal changes in a range of 
physiological systems in the HFHSD fed mice as 
diet has been reported to have pervasive effects on 
health. For example, individuals with insulin 
resistance or diabetes have a higher incidence of 
bone fracture [14, 15] and Alzheimer’s disease 
[16], suggesting that obesity may affect these 
physiological systems in addition to metabolism. 
Therefore, we next tested how HFHSD acutely and 
chronically influenced skeletal and neurological 
health.  
Aging is associated with several bone 
diseases. Consistent with this, chow-fed mice 
displayed an age-related decline in bone mineral 
content (BMC) and bone mineral density (BMD) 
between 24 and 60 weeks of the study (Fig. 2A and 
B). This loss was exacerbated at 24 and 60 weeks 
in HFHSD fed mice (Fig. 2A and B). These 
differences were not related to changes in bone area 
or femur length (Fig. 2C and D). We next assessed 
the microstructure of the distal femoral metaphysis 
by µCT scanning. Trabecular bone volume (Fig. 
2E, M-R) and trabecular number (Fig. 2F, M-R) 
decreased with age in both chow and HFHSD fed 
mice. In addition, by 6 weeks HFHSD fed mice had 
33% less trabecular bone volume (Fig. 2E) and a 
25% less trabecular number compared to age-
matched chow-fed mice (Fig. 2F). Consistent with 
these observations, trabecular separation increased 
with age and was significantly greater in HFHSD 
fed mice (Fig. 2G). Age had no effect on trabecular 
thickness in chow mice (Fig. 2H) but trabecular 
thickness was increased at 24 weeks in HFHSD fed 
mice, but returned to baseline levels after 60 weeks 
(Fig. 2H). In addition, we detected age-related 
changes in cortical bone volume (Fig. 2I) and 
thickness (Fig. 2J), periosteal (Fig. 2K) and 
endosteal perimeters (Fig. 2L) and bone strength 
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(Polar Moment of Inertia (MMIp)) (Fig. 2S) but 
these parameters were not affected by diet, despite 
markedly greater weight in HFHSD fed mice (Fig. 
1E). Together, these data show that HFHSD 
feeding has a rapid and profound effect on bone 
microstructure without significant effects on 
cortical bone or bone strength. Specifically, 
HFHSD feeding appeared to worsen the age-related 
decline in trabecular bone, BMC and BMD.  
High fat high sucrose diet feeding did not 
alter leukocyte telomere length - Since obesity 
exacerbated the age-dependent decline in bone 
microarchitecture, we next tested whether HFHSD 
fed mice exhibited signs of increased biological age 
per se. To do this we assessed telomere length in 
white blood cells. As expected, telomere length 
decreased with age (Fig. 2T), but this decline was 
unaffected by diet. This suggests that HFHSD did 
not generally promote all aspects of aging, and that 
the association found between obesity and age-
related loss in bone quality is rather due to specific 
effects on bone.  
Prolonged high fat high sucrose diet 
feeding impairs short-term memory - To assess 
brain health and cognitive function, we first 
assessed molecular markers of neurodegenerative 
disease susceptibility. Alzheimer’s disease and 
related neurodegenerative diseases are strongly 
associated with the formation of fibrillary plaques 
in the brain. The major components of these 
plaques are forms of β-Amyloid peptide (Aβ), 
Aβ40 and Aβ42 that are generated by proteolytic 
cleavage of amyloid precursor protein. 
Hippocampal Aβ42 content was not changed by age 
or diet (Fig. 3A) but HFHSD fed mice exhibited 
lower levels of the protective Aβ40 after 60 weeks 
compared to age matched chow-fed controls (Fig. 
3B). Despite lower Aβ40 content, we detected no 
difference in the Aβ-40/42 ratio between diets, 
although the Aβ-40/42 ratio decreased with age 
when both diet groups were considered together 
(Fig. 3C).  
Neurodegenerative diseases result in 
behavioural alterations, including depression, 
anxiety and loss of short term memory [17, 18]. We 
next tested whether HFHSD impaired locomotion, 
anxiety or short-term memory. We first performed 
an Open Field Test as a measure of general activity 
and observed that diet had no impact on total 
distance travelled (Fig. 3D) or anxiety, as 
determined by the time spent in the centre of the 
apparatus (Fig. 3E). Similar results were obtained 
when the mice were placed in an Elevated Plus 
Maze, a more specific test for anxiety (Fig. 3F). The 
Y-Maze Test assesses short term working memory 
by measuring spontaneous alternation within the 
maze. No difference was observed in the total 
number of arm entries between chow and HFHSD 
fed mice (Fig. 3G) suggesting that all mice had the 
same level of motivation, curiosity and motor 
function. However, the percentage of alternations 
was lower in HFHSD fed mice, indicative of a 
short-term working memory deficit (Fig. 3H). 
These data indicate that long-term HFHSD feeding 
impaired short-term memory in mice concomitant 
with a decrease in the protective Aβ40 peptide in 
the brain. 
Prolonged high fat high sucrose diet 
feeding overcomes glucose intolerance - To assess 
the impact of HFHSD feeding on glucose 
metabolism we monitored fed and fasting glucose 
concentrations, and glucose tolerance periodically 
throughout the 60 week dietary intervention. Post-
prandial blood glucose concentrations did not differ 
between the diet groups across the 60 week time 
course (Fig. 4A) but fasting blood glucose 
concentrations were elevated in HFHSD fed mice 
from 8 to 52 weeks, after which they returned to 
chow levels (Fig. 4B). As expected glucose 
intolerance was evident in HFHSD fed mice after 1 
week on the diet (Fig. 4C). This same degree of 
glucose intolerance was maintained for 24 weeks 
(Fig. 4C and D). Surprisingly, mice fed a HFHSD 
for more prolonged periods (40-60 weeks) had 
marked improvements in glucose tolerance 
compared to those fed the diet for 1-32 weeks when 
accounting for differences in basal glucose (Fig. 4C 
and D). Over the 60 week time course chow-fed 
mice did not exhibit changes in fasting or fed 
glucose levels or glucose tolerance (Fig. 4A-4D).  
To examine whether improved glucose 
tolerance in HFHSD fed mice was associated with 
improved peripheral insulin sensitivity, we next 
measured insulin-stimulated 2-deoxyglucose 
uptake into white adipose tissue and skeletal muscle 
ex vivo. Insulin-dependent 2-deoxyglucose uptake 
was significantly reduced in both adipose tissue and 
muscles from HFHSD fed mice after 6 weeks of 
feeding and both tissues remained similarly insulin 
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resistant for the duration of the time course (Fig. 4E 
and F). This is in line with the decreased RER 
(Figure 1C) we observed in mice fed HFHSD which 
may be attributed to preferential use of fatty acid 
over glucose for energy. Therefore, the improved 
glucose tolerance observed at 60 weeks of HFHSD 
did not correspond to improved insulin sensitivity 
in peripheral tissues.  
Improved glucose tolerance coincides with 
hyperinsulinemia - To further investigate possible 
mechanisms behind long-term improvements in 
glucose tolerance in HFHSD fed mice we assessed 
the circulating concentrations of key metabolic 
hormones. As expected, leptin concentrations 
correlated with adiposity and were already 
increased after only 6 weeks of HFHSD feeding 
(Fig. 5A). Similarly, GIP was elevated in HFHSD 
fed mice at all-time points (Fig. 5D), while 
interleukin-6 (IL6) was increased only after 60 
weeks and resistin levels were not significantly 
altered (Fig. 5B-5C). Therefore, HFHSD feeding 
affected most of these selected metabolic hormones 
and the rise in GIP, a known incretin, is of interest 
given its role in enhancing insulin secretion and β-
cell proliferation. Indeed, longitudinal analysis of 
circulating insulin levels over 60 weeks HFHSD 
feeding revealed increased fasting and postprandial 
insulin levels starting from 12 weeks and plateauing 
at 40 weeks (Fig. 5E and F). These time points 
correspond with the onset of improved glucose 
tolerance (Fig. 4C and 4D), implying that 
compensatory β-cell enhanced responsiveness may 
contribute to normalisation of glucose tolerance.   
Beta-cell proliferation and adipose 
expansion within pancreata correlates with 
hyperinsulinemia - Increased circulating insulin can 
be driven by decreased insulin clearance, increased 
insulin secretion per β-cell and/or increased β-cell 
mass. Insulin clearance, as measured by the C-
peptide to insulin ratio, was not affected in HFHSD 
fed mice after 60 weeks of feeding (Fig. 5G-5I). 
Therefore, we next examined how HFHSD feeding 
influenced pancreatic morphology and islet number 
(Fig. 6A). Pancreas mass was decreased by ~33% 
at 60 weeks of HFHSD feeding (Fig. 6B) and 
pancreas area showed a similar trend (Fig. 6C). 
Despite decreased pancreas mass (Fig. 6B) the total 
number of islets remained constant (Fig. 6D). 
Given the increase in average islet area (Fig. 6E and 
6F), this suggests an increase in total β-cell mass. 
This was associated with a transient increase in 
Ki67 positive cells at 24 weeks (Fig. 6G), 
suggesting that the increase in β-cell mass was 
likely driven by increased β-cell proliferation. 
Therefore, increased β-cell mass likely contributes 
to the progressive hyperinsulinemia observed in 
mice fed the HFHSD.    
Hyperinsulinemia is not due to greater 
basal insulin secretion per β-cell - Analysis of 
insulin secretion during an I.P. GTT revealed 
greater insulin secretion in HFHSD fed mice at 60 
weeks (Fig. 5G, Fig. 7A). Therefore, we next 
investigated β-cell function by examining glucose-
stimulated insulin secretion (GSIS) in islets from 
chow-fed and HFHSD-fed mice (Fig. 7B-7D). We 
observed hypersecretion of insulin at 2 mM glucose 
and a reduced secretory response at 20 mM glucose 
in HFHSD fed mice after 6-12 weeks on the diet. 
As the mice progressed on the HFHSD (>18 
weeks), the secretory response normalised, such 
that by 60 weeks, islets from mice fed HFHSD 
responded similarly to chow-fed controls (Fig. 7C 
and 7D). These data show that although HFHSD 
feeding induced an acute defect in GSIS, this was 
overcome at longer time points. Despite restored 
GSIS at longer HFHSD time points, these data from 
isolated islets do not support a sole role for an 
increased β-cell response to glucose in contributing 
to the progressive hyperinsulinemia in HFHSD fed 
mice. Rather, they point to a role for increased β-
cell mass and/or exposure to circulating factors 
such as gastric inhibitory polypeptide (GIP) in 
augmenting circulating insulin concentrations. 
High fat high sucrose diet alters islet 
responses to leptin - Our histochemical analysis 
revealed a pronounced proliferation of adipocytes 
in pancreata from HFHSD fed mice (Fig. 6H). This 
reached a maximum at 24 weeks with adipocytes 
making up 5% of the total pancreas volume and, in 
some cases, islets were completely surrounded by 
adipocytes with no apparent cell-to-cell contact 
with acinar tissue (Fig. 6A, lower panel, right inset). 
Based on this observation and the fact the time 
course of this change coincided with the emergence 
of improved glucose tolerance in HFHSD mice we 
surmised that the adaptive hyperinsulinemia maybe 
due to a paracrine effect from local release of 
adipokines from pancreas-associated adipocytes. 
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Based upon our profiling of circulating factors the 
most likely candidate for this effect was leptin (Fig 
5A). Thus, we next examined the effect of leptin on 
GSIS in vitro.  Consistent with the literature [19-
21], leptin inhibited GSIS by ~ 30% in islets from 
chow-fed mice at all-time points (Fig. 7E). 
Strikingly, leptin had no effect on GSIS in islets 
from HFHSD fed mice for up to 32 weeks of 
feeding (Fig. 7E), indicative of leptin resistance, 
whereas leptin potentiated GSIS in mice fed a 
HFHSD for 60 weeks (Fig. 7E). Collectively, these 
data reveal a major effect of leptin to potentiate 
insulin secretion in the context of long-term calorie 
excess.   
DISCUSSION 
This study provides a systematic insight 
into the effects of calorie excess on health. Marked 
deterioration of every physiological system 
examined was observed spanning skeletal muscle, 
liver, bone, brain, adipose tissue and pancreas. 
Exposure of C57BL/6J mice to a HFHSD resulted 
in excess intake of calories, torpor, sarcopenia, 
hepatic steatosis, lipid accumulation in muscle, 
pancreas and heart tissue, pre-diabetes, bone loss 
and impaired neurological function. These findings 
represent some of the major diseases observed in 
aging humans and so this extends previous studies 
to show that overconsumption of calories alone is a 
major risk factor for numerous diseases. The 
temporal onset of these disorders varied 
considerably in the mouse and certain systems 
exhibited a complex dynamic adaptive response. 
This was most notable for the gluco-insular axis 
whereby animals rapidly developed glucose 
intolerance that was ultimately resolved in concert 
with adaptive hyperinsulinemia. The latter was 
partly due to β-cell hyperplasia as well as a novel 
stimulatory effect of leptin on insulin secretion. 
Given that these mice also displayed 
hyperleptinemia, it is conceivable that this leptin 
“switch” plays a role in β-cell compensation under 
these conditions. 
It is noteworthy that aging to 60 weeks had 
limited effect on the metabolic indices measured in 
chow fed control mice. This is despite the presence 
of a truncation mutation in the nicotinamide 
nucleotide transhydrogenase gene [22] in the 
C57BL/6J strain, which has been associated with 
glucose intolerance and insulin secretory 
dysfunction compared to mice without the nnt 
mutation [22]. In agreement with other longitudinal 
studies [23-26], our analysis did not detect any 
significant changes in glucose tolerance, fasting or 
fed circulating insulin levels, 2DG glucose uptake 
into adipocytes and muscle or glucose stimulated 
insulin secretion in these mice throughout the 60 
week feeding period.  
The effect of diet on a range of 
physiological systems has been extensively studied 
and a number of reports have documented 
deleterious effects of high fat diets on skeletal [8, 9] 
and neurological function [12, 13]. Many of these 
studies have been performed in isolation and they 
often do not examine the temporal aspects of these 
perturbations. The strength of the current study is 
that we provide a systematic temporal analysis of 
the consequences of diet-induced obesity on many 
physiological parameters in parallel. This is 
important as it lays the groundwork for a detailed 
longitudinal analysis of the interaction between diet 
and a range of other factors including genetics, 
epigenetics and early development. Such analyses 
are crucial as there is considerable interest in 
precision medicine in humans yet proof-of-
principle for such approaches in model systems like 
mouse is lacking. It is clear from the current study 
that the mouse is a useful system to study the 
ontogeny of a host of diet-induced defects in health. 
Intriguingly, while we observed depreciation in a 
range of physiological systems as noted above there 
was no evidence for obesity increasing biological 
age in general, since telomere length in white blood 
cells was unchanged in HFHSD-fed mice, 
suggesting that these were tissue-specific responses 
to diet. We also observed considerable differences 
in the temporal patterns in that certain defects like 
loss of trabecular bone occurred very rapidly while 
other defects like loss of bone mineral content and 
density and impaired short-term memory occurred 
more slowly.  
The advantage of these temporal 
distinctions is that it is possible to correlate these 
defects with changes in known modulators of bone 
and neurological health. For example, a number of 
factors including activity, load, leptin, insulin and 
IL6 are known to regulate bone health. Both insulin 
and leptin contribute to bone formation and 
extensive investigations have shown that both 
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insulin and leptin resistance play a role in bone loss 
associated with diet-induced obesity [27-29]. IL6 
enhances bone resorption [30]. However, we only 
report evidence for lower activity and leptin and 
insulin resistance by 6 weeks of HFHSD feeding, 
when trabecular bone was compromised. Lower 
activity is known to decrease trabecular bone mass 
[31] and leptin has both a direct and [32] an indirect 
[33] effect on bone metabolism. In addition, high 
mechanical loading (weight) is a dominant stimulus 
of bone mass accretion, yet DIO did not increase 
bone despite increasing body mass by ~20 g. 
Alarmingly, studies in mice have shown that diet-
induced changes in bone health are persistent and 
cannot be completely reversed upon removal of the 
HFHSD challenge (9). Hyperinsulinemia has been 
associated with progression to Alzheimer’s disease 
[12, 13, 34-36]. Accordingly, we detected changes 
in the Aβ40 isoform and cognitive impairment only 
after prolonged exposure to the diet and 
development of marked hyperinsulinemia. Given 
the link between diet and health indices in bone and 
brain, our findings further highlight the need to 
understand how diet, even short-term HFHSD 
consumption, and the associated metabolic 
adaptation including hyperinsulinemia and 
hyperleptinemia, may affect the health of multiple 
organ systems in later life. 
As described previously [23], glucose 
intolerance occurred very rapidly in response to 
HFHSD feeding and this was associated with a 
decline in insulin action in both muscle and adipose 
tissue. However, our temporal analysis of HFHSD 
feeding revealed several novel features of this 
response. First, exactly the same degree of insulin 
resistance and glucose tolerance was maintained for 
24 weeks on the diet with no evidence of a 
progressive deterioration in these systems over this 
time. This was despite a marked increase in muscle 
and liver triglyceride accumulation at 24 weeks of 
HFHSD feeding which occurred at the same time 
that HFHSD-induced increases in adiposity 
plateaued. In fact, insulin resistance in muscle and 
fat was maintained at exactly the same level for the 
entire 60 weeks of the study. This indicates that the 
defect is not cumulative or graded but rather it 
occurs very early after exposure to the diet in a 
switch-like manner. This is intriguing as adipose 
tissue inflammation, which occurs progressively in 
response to HFHSD feeding, was suggested to 
contribute to insulin resistance at later time points 
[37, 38]. But our data from ex vivo assays do not 
support deteriorating insulin responses in adipose 
or muscle, although we cannot rule out differing 
responses in vivo. It was of interest that insulin 
resistance was evident prior to the development of 
fasting or fed hyperinsulinemia in this study 
indicating that the latter may not be the principal 
driver of insulin resistance in HFHSD fed mice. 
Decreased glucose uptake into adipose tissue and 
skeletal muscle could be attributed to preferential 
use of fatty acid over glucose for energy as seen 
with the decreased RER (Fig 1C) in mice fed 
HFHSD.  
Perhaps of most interest was the 
progressive resolution of glucose intolerance with 
prolonged HFHSD feeding, as previously observed 
[25]. This was a very slow process and appears to 
require several discrete but overlapping changes 
including expanded β-cell mass [39, 40] and 
restored insulin secretory function following an 
initial defect in insulin secretion upon transition to 
HFHSD [41, 42]. However, we also observed a 
progressive change in the islet response to leptin, 
beginning with leptin resistance in islets as 
indicated by an inability of leptin to inhibit GSIS, 
as was the case in islets from chow-fed mice. At 
later time points on the HFHSD we observed a 
potentiating effect of leptin on GSIS. Together, it is 
likely that increased circulating insulin in mice fed 
a HFHSD for >24 weeks is driven by a range of 
factors including increased β-cell mass, restored β-
cell secretory responses and altered responses to 
circulating factors such as leptin, GLP1/GIP and 
free fatty acids that act to enhance insulin secretion.  
The relationship between leptin and insulin 
secretion is intriguing; while obesity causes both 
hyperinsulinemia and hyperleptinemia, leptin is 
reported to inhibit GSIS through a direct effect on 
K+ATP channels [19] or indirectly via PI3K-
dependent activation of phosphodiesterase PDE3B 
[20]. Therefore, leptin would be predicted to 
suppress hyperinsulinemia in obesity due to 
increased circulating leptin under these conditions. 
However, our data in isolated islets revealed leptin 
resistance in islets as early as 6 weeks of HFHSD 
feeding. This may be driven by desensitisation to 
leptin since circulating leptin concentrations were 
elevated in HFHSD fed mice at this time. The 
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“switch” in leptin signalling after 60 weeks HFHSD 
feeding is similar to the change in leptin signalling 
output reported in neuronal development [43], and 
is in agreement with phenotypes of pancreas 
specific leptin receptor knock-out mice challenged 
with HFHSD [21] and in mice with deletion of the 
leptin receptor both in β-cells and hypothalamus 
[44]. These mice develop obesity, fating 
hyperinsulinemia and impaired glucose stimulated 
insulin secretion; consistent with a stimulatory role 
of leptin signalling on insulin secretion during 
obesity [45]. Taken together with our observations, 
these data suggest that leptin exerts a different role 
on β-cell function depending on the nutritional 
context and it will be of interest to understand the 
mechanism underlying this switch. It is tempting to 
speculate that the effect of leptin observed in ex vivo 
assays may be exacerbated in vivo through 
paracrine delivery of leptin from local adipose 
tissue within pancreata. Indeed, these 
intrapancreatic adipocytes that we observed in 60 
weeks HFHSD fed mice may also provide a local 
source of lipid intermediates and/or adipokines that 
are known to modulate GSIS. We have previously 
reported an effect of FABP4 released from 
adipocytes to potentiate insulin secretion in mice 
and this could also contribute to the compensatory 
hyperinsulinemia [46]. Overall, induction of leptin 
resistance at early time points of HFHSD feeding 
may prevent leptin-induced inhibition of GSIS and 
permit compensatory hyperinsulinemia. The later 
functional switch in leptin signalling may 
contribute to the restoration of glucose homeostasis 
observed at 60 weeks, given the hyperleptinemia 
and increased pancreatic adipose tissue at this time 
point. 
Insulin resistant humans often exhibit 
normal glucose tolerance due to increased insulin 
secretion [47, 48]. This is distinct from acute 
responses to HFHSD in C57BL/6J mice, which 
become glucose intolerant without 
hyperinsulinaemia. In contrast, the metabolic 
phenotype measured in C57BL/6J mice fed a 
HFHSD for 42-60 weeks more closely mimic the 
human condition. Further, the delayed adaptive 
response in insulin secretion to overcome insulin 
resistant in C57BL/6J mice allowed us to pinpoint 
factors that may contribute to increased insulin 
secretion, including a novel role of leptin in this 
process. The dynamics of  increased insulin 
secretion in response to HFHSD  may be 
determined by genetic background since other 
mouse strains more rapidly increase insulin 
secretion in response to HFHSD [49]. It will be of 
interest to determine to what extent compensatory 
hyperinsulinaemia in mice with different genetic 
backgrounds and humans is driven by altered β-cell 
responsiveness to leptin.  
These studies reveal that in the C57BL/6J mouse 
diet has a potent and pervasive effect on the health 
of the metabolic, skeletal and neurological systems. 
Most of these defects represent some of the most 
common defects observed with age in humans, such 
as loss of bone structure and cognitive decline. 
However, diet did not appear to accelerate general 
ageing since the age-dependent decline in telomere 
was unaltered in HFHSD fed mice. This gives rise 
to the possibility that many of these defects may 
represent the cumulative exposure to different toxic 
intermediates as a result of over nutrition and may 
not be part of the aging process per se. One of the 
most surprising results observed here was the age 
dependent resolution in glucose tolerance, which 
was concomitant with increased β-cell mass, 
increased circulating insulin, and a “switch” in β-
cell responses to leptin. These studies give rise to a 
number of intriguing questions worthy of further 
investigation: do all of these diseases have the same 
point of origin or do they occur independently; what 
other factors might work in concert with diet to 
increase the risk of certain defects preferentially 
over others; and do these defects arise from the diet 
itself or is this simply a consequence of a persistent 
state of positive energy balance that might be 
observed following over-consumption of any types 
of nutrients? Answering these questions will 
provide substantial advances to our understanding 
of the interaction between diet, obesity and long 
term health.  
EXPERIMENTAL PROCEDURES 
Animals - Male C57BL/6J mice (7 weeks 
(weeks) old) were obtained from the Animal 
Resources Centre (Perth, WA, Australia) and 
acclimatized for 1 wk prior to experiments. Mice 
were maintained on a 12 h light/dark cycle 
(0700/1900 h) and given ad libitum access to food 
and water. Experiments were carried out in 
accordance with the National Health and Medical 
Research Council (NHMRC; Australia) guidelines 
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for animal research and were approved by Garvan 
Institute/St Vincent’s Hospital and the University 
of Sydney Animal Experimentation Ethics 
Committees. To assess the effect of diet on overall 
health, we periodically measured changes in body 
weight, adipose and muscle mass, glucose 
tolerance, insulin resistance, pancreatic β-cell 
function, bone and neurological health in mice fed 
a HFHSD for up to 60 weeks. Most measurements 
were taken at 6, 24 and 60 weeks following 
initiation of diet. To ensure that data was not biased 
by cage to cage variability, studies were performed 
in multiple cohorts at two institutes. Data presented 
are a minimum of 8 mice. Further, individual 
cohorts were split into 2 groups so that glucose 
tolerance testing and sacrifice could be carried out 
within a 2 h period.  
Experimental diets - Age matched mice 
were maintained on either a standard lab chow 
(13% calories from fat, 65% carbohydrate, 22% 
protein from Gordon’s Specialty Stock Feeds, 
Yanderra, NSW, Australia) or HFHSD (47% fat 
[7:1 lard-to-safflower oil ratio], 32% carbohydrate, 
21% protein) and water. Food intake was measured 
cumulatively over 5 d by measuring the weight of 
the food before and after the allocated time, minus 
spillage. To calculate energy consumption the 
weight of food consumed was multiplied by the diet 
energy density. 
Body composition and mouse activity - 
Body composition was determined using Dual-
energy x-ray absorptiometry (DEXA) (Lunar 
PIXImus2 densitometer; GE Healthcare) in 
accordance with the manufacturer’s instructions. 
Oxygen consumption rate (VO2) and respiratory 
exchange ratio (RER) were measured under a 
consistent environmental temperature (22°C) using 
an indirect calorimetry system (Oxymax series, 
Columbus Instruments). For mice, studies were 
commenced after 2 h of acclimation to the 
metabolic chamber using an air flow of 0.6 L/min. 
VO2 was measured in individual mice at 27-min 
intervals over a 24 h period. During the studies, 
chow and HFHSD mice had ad libitum access to 
food and water. Activity was quantified as the total 
number of beam breaks that occurred per 24 h while 
housed in the calorimetry chamber. 
Tissue glycerol content as a measure of 
tissue triglycerides - Frozen tissue was powdered, 
and lipids extracted using a standard chloroform: 
methanol procedure. Triglyceride content was 
determined using an enzymatic colorimetric assay 
kit following the manufacturer’s instructions 
(Triglycerides GPO-PAP; Roche Diagnostics).  
Bone health measures - Left and right 
femora were fixed in 4% paraformaldehyde for 16 
h then transferred to 70% ethanol. Femora length 
measured using calipers (Mitutoyo, Illinois USA). 
Femoral BMC and BMD were measured using the 
DXA (Lunar PIXImus2 densitometer; GE 
Healthcare). The distal end of the right femur was 
scanned using micro-computed tomography (µCT) 
with a Skyscan 1172 scanner and associated 
analysis software (Skyscan)[50]. Femoral Images 
were captured at a resolution of 4.37 µm. The 
trabecular region of interest (ROI) was defined as 
100-800 µm from the growth plate [9]. The 
following parameters were generated: total bone 
volume (TV), trabecular bone volume (BV), 
trabecular bone thickness, trabecular number and 
trabecular separation. For cortical bone volume and 
thickness the ROI was defined as 2500-3500 µm 
from the growth plate. Endosteal and periosteal 
perimeters were traced and measured from the 
uppermost slice of the cortical ROI (3500 µm from 
the growth plate) and the average, γ, maximum and 
polar moment of inertia (MMI) (an index of 
bending strength) was calculated. All data was 
generated using CT-Analyzer software (Skyscan). 
Telomere length assay - To obtain white 
blood cells, EDTA-anticoagulated blood taken 
from cardiac puncture (typically 600 -1000 µL) was 
centrifuged at 1500 x g for 15 min at 4oC. The white 
blood cell layer was isolated and DNA extracted 
using DNeasy blood and tissue kit from Qiagen 
following the manufacturer’s instructions. DNA 
was quantified using SyBr green (Life 
Technologies). Telomere length was quantified by 
qPCR, using primers for the telomeric sequence and 
genomic control 36B4 as described previously [51]. 
10 ng genomic DNA was amplified in 10 µL 
reactions using 0.25 µM forward and reverse 
primers, using the Universal FastStart SyBr Green 
qPCR kit (Roche Diagnostics) in a 384-well plate 
format with the Roche LightCycler480 instrument. 
Cycling conditions included an initial 10 min 
denaturation step at 95oC, followed by 40 cycles of 
15 s at 95oC and 1 min at 60oC, and concluded with 
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a melt-curve between 60oC and 95oC. Serial 
dilutions of pooled samples were used to assess 
PCR efficiency and generate standard curves for 
quantifying relative telomere and 36B4 levels. 
Telomere levels were normalised to 36B4 levels to 
obtain relative telomere length. 
Amyloid beta 40, 42 measurements - Brain 
tissue was carefully dissected from the skull, snap 
frozen and stored at -80 oC until use. Hippocampi 
from chow and HFD fed mice were weighed and 
homogenized in 8x 5 M guanidine HCl/ 50 mM Tris 
HCl and further diluted in BSAT-DPBS containing 
a protease cocktail inhibitor. The supernatant was 
collected for the soluble Aβ ELISA. The Aβ levels 
were determined by using the commercially 
available ELISA kits (Mouse Aβ42 – KMB3441, 
Mouse Aβ40 – KMB3481, Invitrogen). Total 
protein was quantified using the Bradford reagent 
and Aβ40 and 42 levels were normalised 
appropriately.  
Behavioural measurements  
Open Field - The Open Field test was 
conducted as previously described [52]. The open 
field test arena (40 x 40 cm) was situated in a large 
box with clear plexiglass walls, no ceiling, and a 
white floor. Each chamber was set inside a larger 
sound-attenuating cubicle with lights illuminating 
the arena and a fan to eliminate background noise. 
Mice were placed into the centre of the arena and 
allowed to explore the test box for 10 min, while a 
computer software program (Activity Monitor; 
Med Associates) recorded activity via photobeam 
detection inside the testing chambers. The total 
distance travelled over the course of the 10 min was 
recorded as a measure of general activity levels. 
The arena was cleaned with 70% EtOH between 
each mouse.  
Behavioural measurements 
Elevated plus maze - The elevated plus 
maze was performed as previously described [52]. 
The elevated plus-maze consists of four arms (77 x 
10 cm) elevated (70 cm) above the floor. Two of the 
arms contained 15 cm-high walls (enclosed arms) 
and the other two consisted of no walls (open arms). 
Each mouse was placed in the middle of the maze 
facing a closed arm and allowed to explore the maze 
for 5 min. A video camera recorded the mouse and 
a computer software program (Limelight; Med 
Associates) was used to measure the time spent in 
the open arms, as an indication of anxiety-like 
behaviour. The maze was cleaned with 70% EtOH 
between each mouse. 
Y-maze - The Y-maze was performed as per 
Heneka et al. [53], with modification. Testing was 
conducted in an opaque Plexiglass Y maze 
consisting of three arms (40 x 4 x 17 cm high) 
diverging at a 120-degree angle. Each mouse was 
placed in the centre of the Y-maze and allowed to 
explore freely through the maze during a 5 min 
session. The sequence and total number of arms 
entered was recorded. Arm entry was only counted 
when all four paws of the mouse were in the arm. 
Visits to each of the 3 arms consecutively was 
considered a triad.  Percentage alternation was 
calculated as the number of triads divided by the 
maximum possible alternations (the total number of 
arms entered minus 2) × 100. The maze was cleaned 
between each mouse with 70% EtOH.  
Glucose tolerance testing (glucose, insulin 
and c-peptide measurements). For the majority of 
glucose tolerance tests mice were fasted for 6 h 
beginning at 0800 h, before administration of an 
intraperitoneal injection of a 10% glucose solution 
to achieve a final dose of 1g/kg of fat-free mass 
(FFM). For experience to measure insulin clearance 
by assessing circulating insulin and C-peptide (Fig. 
5G-I), mice where fasted for 16 h overnight. Blood 
glucose was measured at time points indicated in 
whole blood sampled from the tail tip using an 
Accu-Check II glucometer (Roche Diagnostics) 
Blood samples were obtained via tail tip at 0, 15, 
30, 60 90 and 120 mins, using 5 μL heparinised 
hematocrit tubes (Drummond) and ejecting samples 
into a mouse ultrasensitive insulin ELISA (90080, 
Crystal Chem) or C-peptide ELISA (90050, Crystal 
Chem). Postprandial measurements were taken at 
0700 h, and fasting measurements were taken prior 
to the GTT at 1400 h. 
In vitro glucose uptake in adipose -
Epididymal adipose depots were removed from 
mice, and immediately incubated in DMEM 
supplemented with 2% BSA and 20 mM HEPES, 
pH 7.4 at 37°C. Visible non-parenchymal tissue 
was then removed, and explants were minced into 
fine pieces. Minced explants were washed twice 
and incubated in DMEM supplemented with 2% 
BSA and 20 mM HEPES, pH 7.4 for 2 h. Adipose 
explants were washed in Modified Krebs-Ringer 
Phosphate buffer (KRP) [54] supplemented with 
2% BSA, before stimulation with 0.5 or 10 nM 
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insulin for 20 min where indicated at 37°C. During 
the final 5 min, 50 μM unlabelled 2-deoxyglucose 
(2-DOG) containing 1 μCi/mL of [3H]2-DOG and 
0.14 μCi/mL [14C]-Mannitol was added (total 
volume 0.5 mL). Glucose/tracer uptake was 
stopped with three washes in ice-cold PBS, 
quantified by liquid scintillation spectroscopy and 
corrected for extracellular [14C]-mannitol and 
protein content [55-57].  
In vitro glucose uptake in muscle - 
Extensor Digitorum Longus (EDL) and soleus 
muscles were excised, mounted and pre-incubated 
for 30 min at 30°C in Krebs Henseleit buffer 
containing 5.5 mM glucose, 2 mM pyruvate and 
0.1% BSA (KRH) [58]. KRH was gassed with 
carbogen (95% O2/5% CO2). Glucose uptake was 
assessed in KRH containing 0.375 µCi/ml [3H]-2-
DOG and 0.05 µCi/ml [14C]-Mannitol in a final 
volume of 2 mL for 20 min at 30°C, with or without 
100 nM insulin before muscles were washed in ice-
cold PBS and snap frozen. Frozen muscles were 
incubated in 1 M potassium hydroxide at 70°C for 
20 min. Tracer content was quantified by liquid 
scintillation spectroscopy (Beckman LS6500 
counter) and cellular glucose uptake calculated 
after correcting the [3H]-2-DOG counts for 
extracellular [14C]-mannitol counts and tissue 
weight [55, 57]. 
Isolation of mouse pancreatic islets - Islets 
were isolated using collagenase/thermolysin 
digestion and handpicking under a 
stereomicroscope as described [57, 59] with 
modification. Briefly, 0.25 mg/mL Liberase 
(Sigma-Aldrich) in HBSS (GIBCO) with 20 mM 
HEPES was injected into the common bile duct. 
The pancreas was removed and incubated at 37°C 
in a shaking water bath for 13 min. After 2 washes, 
the digested pancreas was passed through a 1,000-
mm mesh and subjected to a Histopaque 1119 and 
1077 (Sigma-Aldrich) gradient. As a final 
purification, islets were hand-picked in HEPES 
Krebs Ringer buffer (KRBH) (20 mM HEPES, pH 
7.4; 119 mM NaCl; 4.75 mM KCl; 2.54 mM CaCl2; 
1.2 mM MgSO4; 1.18 mM KH2PO4; 5 mM 
NaHCO3) containing 5 mM glucose and 1 mg/mL 
BSA. Handpicked islets were then recovered in 
RPMI media supplemented with 11 mM glucose 
and 10% FBS for 1 h before insulin secretion was 
assessed.   
Islet insulin secretion - Islet static insulin 
secretion assays were performed previously 
described [59] with the following modifications. 
After recovery islets were transferred into KRBH 
containing 2.8 mM glucose and pre-incubated at 
37°C for 1 h. At the end of the pre-incubation five 
islets of equivalent size were placed in KRBH 
supplemented with 2.8 or 16.7 mM glucose in the 
presence or absence of 20 ng/mL Leptin for 1 h. The 
tubes were centrifuged at 1500 RPM for 5 min and 
the islet incubation media collected and frozen for 
insulin determination by an ELISA (Crystal Chem). 
The islet pellet was sonicated in in 50 µL of lysis 
buffer (100 mM Tris, 300 mM NaCl, 10 mM NaF, 
2 mM Na Orthovanadate) for determination of 
DNA concentration (Quant-iT Picogreen DNA kit, 
Thermo Fisher) and total insulin content (ELISA, 
Crystal Chem) of the islets. Insulin secretion and 
insulin content data are expressed relative to DNA 
content.   
Pancreatic immunohistochemistry - 
Pancreata were removed, cleared of fat and lymph 
nodes and fixed in 10% buffered formalin, 
transferred to 70% EtOH, embedded in paraffin and 
serial sectioned (5 μm sections) and mounted on 
Superfrost Plus slides (Fisher Scientific, Pittsburgh, 
PA). Slides were rehydrated, then transferred to 
water. Antigen retrieval was performed by 
submerging slides in the Target Retrieval solution 
(Dako – S1699) and heating to 125°C for 1 min and 
95°C for 10 s before being cooled. Slides were 
placed in blocking solution (PBS containing 2% 
BSA, 5% goat & 5% donkey serum (Sigma)) for 30 
min at room temperature, then incubated in a 
primary antibody solution (Blocking solution + 1° 
antibody) containing 1° antibody overnight at 4°C. 
The following day slides were washed 3 x with T-
TBS (0.1% tween) followed by a 1 h incubation at 
room temperature in secondary antibody solution 
(PBS + 2% BSA (Sigma) + 2° antibody). Anti-
insulin (Cat. No. I8510) and anti-glucagon (Cat. 
No. G2654) antibodies were from Sigma-Aldrich 
and anti-Ki67 (RM-9106-S0) antibodies and DAPI 
were from Thermo Fisher Scientific. We quantified 
3-4 pancreata per diet at each time point using 3 
sections at least 150 µm apart from each other. 
Whole sections were imaged and stitched on a 
Leica DM6000 Power Mosaic using a 40x PLAN 
APO objective. Image analysis was performed 
using custom image analysis pipelines deployed 
across the ilastik [60], Fiji [61] and WEKA [62] 
platforms. For gross measurements of pancreas, 
islet and adipose tissues, classifiers generated using 
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ilastik were used to generate pixel based probability 
maps for features of interest. These were segmented 
and measured in Fiji using a series of custom 
macros for complex/difficult segmentation the 
primary segmentation was cleaned with a second 
round of machine learning, prior to final analysis. 
Nuclei and Ki-67 were segmented and counted in 
previously detected islets using custom macros. In 
total we imaged and analysed 3567 mm2 of 
pancreas tissue in which we detected 11001 islets 
that contained 294158 nuclei. 
Statistics - Data analysis was carried out 
using Prism 6 software (v6.01). Statistical 
significance was set at P<0.05. P values were 
calculated by Mann-Whitney test, Wilcoxon 
signed-rank test, where indicated. Where 
appropriate, sub-groups were initially compared by 
two-way ANOVA. If row or column factors were 
significant, specific sub-groups were then 
compared using Student’s t-test (adjusting for 
multiple comparisons using the Sidak method). 
Data are expressed as mean ± SEM of the 
replicates. All glucose tolerance area under curve 
(AUC) calculations were performed in Prism 6 
software (v6.01) and were corrected for baseline. 
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FIGURE LEGENDS 
Figure 1. High fat high sucrose diet increases body weight and adiposity. (a-b) Food intake (a) was 
measured after 60 weeks of either chow (black bars) or HFHSD (white bars) feeding and daily energy intake 
(Kcal/day/mouse) calculated (b). Data are mean ± SEM, Mann-Whitney, n= 7 chow and 8 HFHSD mice, * 
p<0.05 vs chow-fed controls. (c-d) Respiratory exchange ratios (c) and activity (number of beam crosses 
within 24 h) (d) were assessed in mice fed a chow or HFHSD for indicated times (weeks = wks). Data was 
separated in to light and dark cycles. Data are mean ± SEM, n= 4 chow and HFHSD for 6 weeks , 4 chow 
 by guest on February 15, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
  Caloric excess and multiple health defects in mice 
16 
 
and HFHSD for 24 weeks , 8 chow and HFHSD for 60 weeks, t-tests corrected for multiple comparisons, 
* p<0.05 vs age-matched chow controls. (e-f) Body mass n= 28-54 mice for chow and 27-54 for HFD (e) 
and percentage adiposity, n= 8-24 mice for chow and 10-31 for HFHSD(f) of mice fed a chow (black line) 
or HFHSD (grey line) for indicated times. (g) Triglyceride content in liver, quadriceps and heart tissue from 
mice fed a chow or HFHSD for indicated times, n= 9-23 for quad,  9-10 for liver and 3-9 for heart. (h-i) 
Total lean mass, n= 28-54 for chow mice and 27-54 for HFHSD mice, (h) and quadriceps mass, n=9-10, (i) 
in mice fed a chow or HFHSD for indicated times. Data are mean ± SEM, t-tests corrected for multiple 
comparisons (g and i), * p<0.05, vs chow-fed age-matched controls, † p <0.05 vs mice fed either diet for 6 
weeks (i). 
 
Figure 2. High fat high sucrose diet rapidly impairs skeletal structure. (a-c) Femora were isolated from 
mice fed chow (black bars) or HFHSD (white bars) for 6, 24 and 60 weeks (wks) and DXA scanning utilised 
to measure femoral bone mineral content (BMC) (a), bone mineral density (BMD) (b) and bone area (c). 
(d) Length of femurs from mice fed chow or HFHSD for indciated times. (e-h) Micro-CT scanning of 
tarbecular bone from mice fed chow or HFHSD for -indicated times assessed trabecular bone volume/total 
volume (e), trabecular number (f), trabecular separation (g) and trabecular thickness (h). Cortical bone from 
mice fed chow or HFHSD for indicated times was assessed for cortical bone volume (i) and cortical 
thickness (j). (k-l) Periosteal (k) and endosteal (l) perimeters were measured from mice fed chow or HFHSD 
for indicated times. (m-n) Representative images showing the loss in trabecular bone volume, and trabecular 
number and changes in cortical thickness in mice fed chow or HFHSD for 6 (m, n), 24 (o, p) and 60 (q, r) 
weeks, respectively. (s) Polar moment of inertia (was calculated using the Skyscan CT analyser software 
as an indicator of bone strength in isolated femurs. (t) Relative telomere length in mice fed a chow or 
HFHSD for 6 or 60 weeks. Data are mean ± SEM, . n=10,10 and 18 mice per group for 6,12 and 60 weeks 
respectively , t-tests corrected for multiple comparisons,* p <0.05 vs age matched chow, † p <0.05 vs mice 
fed either diet for 6 weeks, # p <0.05 vs mice fed either diet for 24 weeks as indicated. 
 
Figure 3. Prolonged high fat high sucrose diet feeding impairs short term memory. (a-c) Hippocampal Aβ 
42 (a) and 40 (b) were measured and the Aβ-40/42 ratio calculated for mice fed a chow (black bars) or 
HFHSD (white bars) for indicated times (weeks = wks) (c). (d-h) Mice fed a chow or HFHSD for 60 weeks 
were subjected to the open field test (d-e), elevated plus maze (f) and Y-maze (g-h). The open field test 
provided a measure of locomotion (d) and anxiety as measured by time in the centre of the apparatus (e). 
(f) Elevated plus maze directly measured anxiety by quantifying time in open arms of the maze. (g-h) The 
Y-maze provided a measured of activity (g) by measuring number of entries into arms of the maze and short 
term spatial memory by quantifying the number of entries into alternate arms of the maze (alternations) (h). 
Data are mean ± SEM, n= 5 per group for 6 and 24 week mice, n=8 for 60 week chow and n=11 for 60 
week HSHFD mice. t-tests corrected for multiple comparisons,* p <0.05 vs age matched chow, † p <0.05 
vs mice fed either diet for 6 weeks as indicated. 
 
Figure 4. Glucose tolerance in high fat high sucrose diet fed mice resolves with prolonged exposure to high 
fat high sucrose diet. (a-b) Postprandial (a), n=18-41 and fasting (b), n=10-30, blood glucose concentrations 
in mice fed a chow (black line) or HFHSD (grey line) for indicated times (weeks = wks). Data are mean ± 
SEM, t-tests corrected for multiple comparisons* p<0.05 vs chow-fed controls. (c) Area under the curve 
calculated from blood glucose concentrations during glucose tolerance tests in mice fed a chow (black bars) 
or HFHSD (grey bars) for indicated times. Data are mean ± SEM, n=7-42, t-tests corrected for multiple 
comparisons, * p<0.05 vs chow-fed age matched controls. (d) Representative blood glucose concentrations 
during a glucose tolerance test in C57BL/6J mice fed a chow or HFHSD for 6, 24 or 60 weeks. Data are 
mean ± SEM, n=  20-25 at 6 weeks, 38-39 at 24 weeks , 20-26 at 60 weeks, t-tests corrected for multiple 
comparisons,* p<0.05 vs chow-fed controls. (e) Rates of 3H-2DOG uptake into epididymal adipose 
explants from mice fed a chow or HFHSD for 6, 24 weeks or 60 weeks under unstimulated conditions and 
in response to 0.5 nM or 10 nM insulin. Data are mean ± SEM, n=4-10, t-tests corrected for multiple 
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comparisons, † p<0.05 vs 0.5 nM insulin chow mice, # p<0.05 vs 10 nM insulin chow mice. (f) Rates of 
3H-2DOG uptake into isolated soleus muscles (left panel) or EDL (right panel) muscles from mice fed a 
chow or HFHSD for 6, 24 or 60 weeks under unstimulated conditions (basal) and in response 10 nM insulin. 
Data are mean ± SEM, n- 5-14, t-tests corrected for multiple comparisons, # p<0.05 vs 10 nM 0 d HFHSD. 
 
Figure 5. Prolonged high fat high sucrose diet feeding induces hyperinsulinemia. (a-d) Concentrations of 
leptin (a), resistin (b), IL6 (c) and gastric inhibitory polypeptide (GIP) (d) in serum from mice fed a HFHSD 
(white bars) for indicated times and chow-fed controls (black bars) (weeks = wks). Data are mean ± SEM, 
n=4-12, t-tests corrected for multiple comparisons, * p<0.05 vs chow-fed controls. (e) Postprandial and (f) 
fasting circulating insulin levels in mice fed a HFHSD (grey line) for specified times and chow-fed controls 
(black line). Data are mean ± SEM, n=7-30, t-tests corrected for multiple comparisons,* p<0.05 vs chow-
fed controls. (g-i) Circulating insulin (g) and c-peptide (h) concentrations during an I.P GTT following an 
overnight fast in mice fed chow or HFHSD for 60 weeks. The C-peptide/insulin ratio (i) was calculated 
from (g) and (h). Data are mean ± SEM, n=8-9, t-tests corrected for multiple comparisons, * p<0.05 vs 
chow-fed controls. 
 
Figure 6. β-cell hyperplasia in high fat high sucrose diet fed mice. (a) Representative images of pancreatic 
slices from mice fed a HFHSD for indicated times (weeks = wks) and chow-fed controls stained for nuclei 
(DAPI, blue), insulin (red) and glucagon (green). (b) Pancreatic mass from mice fed chow (black bars) or 
HFHSD (white bars) for indicated times. Data are mean ± SEM, t-tests corrected for multiple comparisons, 
* p<0.05 vs chow-fed controls.  (c-f) tissue area (c), number of islets per pancreas (d), average islet area (e) 
and islet area as a percentage of pancreas area (f) was calculated from pancreas images (a). Data are mean 
± SEM, t-tests corrected for multiple comparisons, * p<0.05 vs chow-fed controls. (f) Pancreatic sections 
were stained with Ki67 as a measure of cell proliferation and Ki67 positive islets quantified. (g) Adipocytes 
within pancreatic slices was quantified. Data are mean ± SEM, t-tests corrected for multiple comparisons, 
* p<0.05 vs chow-fed control, n=4 mice per group with 3 sections per pancreas. 
 
Figure 7. High fat high sucrose diet feeding switches islet responses to leptin. (a) Change in blood insulin 
concentration during the first 7.5 min of an I.P. GTT performed on mice fed chow (black bars) or HFHSD 
(white bars) for 60 weeks. Data reanalysed from Fig. 5G. Data are mean ± SEM, n=8-9, Mann-Whitney 
with correction for multiple comparisons, * p <0.05 vs chow response.  (b-d) Insulin secretion from primary 
islets isolated from mice fed chow or HFHSD for indicated times and incubated with 2, 11 or 20 mM 
glucose. Data from control mice and mice fed a HFHSD for 6 and 12 weeks (wks) (b), 18, 24 and 32 weeks 
(c) were similar and so were combined for statistical power. Data are mean ± SEM, n= 19 at 6-12 weeks, 
17 at 18-24 weeks and 15 at 60 weeks, t-tests corrected for multiple comparisons, * p <0.05 vs chow 
response at same glucose concentration. (e) Insulin secretion in response to 11 and 20 mM glucose was 
assessed in the presence of 20 ng/mL leptin. Percentage change in insulin secretion was calculated per 
mouse. Data are mean ± SEM, Wilcoxon signed-rank test to test for difference from 0, * p<0.05. n= 16 and 
18 at 6-12 weeks; 23 and 18 at 18-32 weeks; 25 and 27 at 60 weeks for chow- and HSHFD-fed mice, 
respectively. 
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Figure 5
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Figure 7
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